Inventor · disambiguated record
Liu Xue
Also filed as: XUE LIU
7 granted patents·14 pending applications·12 citations·filing 2012–2025
78Inventor score
Files withBEIGENE SWITZERLAND GMBH9BEIGENE LTD6UNIV KENTUCKY RES FOUND3BEONE MEDICINES I GMBH2ZHAN CHANG-GUO1
Top patents by PatentIndex Score
21 records- 0193US11203637B2Anti-Tim-3 antibodies and use thereofBEIGENE LTD·Filed 2017·Granted Dec 21, 2021·8 cites·29 claims
- 0279US2024076375A1Anti-TIM-3 Antibodies and Use ThereofBEIGENE SWITZERLAND GMBH·Filed 2023·Application pending·0 cites
- 0378US10772940B1Cocaine hydrolase-FC fusion proteins for cocaine and methods for utilizing the sameUNIV KENTUCKY RES FOUND·Filed 2013·Granted Sep 15, 2020·3 cites·7 claims
- 0477US11214616B2Anti-TIGIT antibodies and their use as therapeutics and diagnosticsBEIGENE LTD·Filed 2018·Granted Jan 4, 2022·1 cites·11 claims
- 0575US12234286B2Anti-TIGIT antibodies and their use as therapeutics and diagnosticsBEIGENE SWITZERLAND GMBH·Filed 2021·Granted Feb 25, 2025·0 cites·20 claims
- 0670US2022135675A1Anti-tim-3 antibodies and use thereofBEIGENE LTD·Filed 2021·Application pending·0 cites
- 0769US2022251195A1Anti-tigit antibodies and their use as therapeutics and diagnosticsBEIGENE SWITZERLAND GMBH·Filed 2022·Application pending·0 cites
- 0866US9365841B1High activity mutants of butyrylcholinesterase for cocaine hydrolysisUNIV KENTUCKY RES FOUND·Filed 2014·Granted Jun 14, 2016·0 cites·2 claims
- 0966US2025075002A1MUC1 and CD16A Antibodies and Methods of UseBEIGENE SWITZERLAND GMBH·Filed 2024·Application pending·0 cites
- 1066US2024301061A1Anti-cldn6 and anti-cd3 multispecific antibodies and methods of useBEIGENE SWITZERLAND GMBH·Filed 2024·Application pending·0 cites
- 1166US2025115671A1Anti-ccr8 antibodies and methods of useBEIGENE LTD·Filed 2024·Application pending·0 cites
- 1266US2024301062A1Anti-cd3 multispecific antibodies and methods of useBEIGENE SWITZERLAND GMBH·Filed 2024·Application pending·0 cites
- 1364US2025154279A1Anti-gpc3 and anti-cd137 multispecific antibodies and methods of useBEIGENE LTD·Filed 2024·Application pending·0 cites
- 1463US8945901B1High activity mutants of butyrylcholinesterase for cocaine hydrolysisUNIV KENTUCKY RES FOUND·Filed 2013·Granted Feb 3, 2015·0 cites·5 claims
- 1563US2024190990A1Anti-cea antibodies and methods of useBEIGENE SWITZERLAND GMBH·Filed 2023·Application pending·0 cites
- 1657US2023391883A1Methods of Cancer Treatment Using Anti-TIGIT Antibodies in Combination with Anti-PD1 AntibodiesBEIGENE SWITZERLAND GMBH·Filed 2022·Application pending·0 cites
- 1753US8592193B1High activity mutants of butyrylcholinesterase for cocaine hydrolysisZHAN CHANG-GUO·Filed 2012·Granted Nov 26, 2013·0 cites·5 claims
- 1853US2024376195A1ANTI-NKp30 ANTIBODIES AND METHODS OF USEBEIGENE LTD·Filed 2021·Application pending·0 cites
- 1952US2025382384A1MUC1 Antibodies and Methods of UseBEONE MEDICINES I GMBH·Filed 2025·Application pending·0 cites
- 2047US2025295798A1Ligand-drug conjugate of exatecan analogue, and medical use thereofBEIGENE SWITZERLAND GMBH·Filed 2025·Application pending·0 cites
- 2145US2025312473A1B7h3 antibody drug conjugatesBEONE MEDICINES I GMBH·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Liu Xue files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →